Call Protection: NC2-3 (50%, 25%, Par). MWC at B+50bp. Equity claw: 40% up to 3 years. Special call: 10% per year for the first 2 years at 103.
Use of Proceeds: Along with proceeds from equity contribution, and a USD/EUR term loan B 2-part (US$500m minimum and €500m minimum) (total loan and bond deal size CHF1.38bn equivalent), to fund the CHF2bn purchase price for the acquisition of a 60% interest in Capsugel by Lone Star from Lonza Group AG (which will retain a 40% minority interest) and provide for cash overfunding to the balance sheet.
Joint Global Coordinators and Physical Bookrunners: GS (B&D), Jefferies, BNP, and UBS
Joint Bookrunners: BBVA, ING, IMI - Intesa Sanpaolo, RBI, SocGen, UniCredit, and Standard Chartered
Listing: ISE
Governing Law: NY Law
Denominations: €100k x €1k
Equity Sponsor: Lone Star
Equity Contribution: CHF823m, including Lonza's rollover equity.
Roadshow (virtual meetings): Started 27-Apr-26
Global Investor Call: 15:00 UKT / 10:00 ET 27-Apr-26
Commitments Due: USD TLB 30-Apr-26 17:00 NYT / 22:00 UKT; EUR TLB 01-May-26 11:00 UKT / 06:00 NYT
Timing: Possible pricing 01-May-26
We use functional cookies to make this site work properly and marketing cookies to personalize content. By continuing or clicking "Ok", you consent to our use of cookies. See our Cookie Policy for more information.